
Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
Author(s) -
Xinxin Zhu,
Zong-Hao Feng,
Lin-Zhi Liu,
Yan Zhang
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001363
Subject(s) - liraglutide , endocrinology , medicine , endometrial cancer , cell growth , chemistry , cell culture , biology , cancer , biochemistry , diabetes mellitus , type 2 diabetes , genetics